Diamox Acetazolamide Tablets

Diamox is a brand name for acetazolamide, a medication primarily used to treat glaucoma, epilepsy, and altitude sickness. The brand was originally developed by Wyeth Pharmaceuticals, an American pharmaceutical company. In 2009, Wyeth was acquired by Pfizer Inc., a leading global pharmaceutical corporation headquartered in New York City, USA. As a result, Pfizer became the ultimate owner of the Diamox brand. The manufacturing of Diamox occurs in multiple countries, reflecting Pfizer's global production capabilities. The medication is available in various forms, including oral tablets and intravenous solutions, and is distributed worldwide under the Diamox brand name.